Every year over 35,000 children born with a congenital heart defect is in need for some type of reconstructive surgery.  CryoLife's dedication to improve human kind through advancement in biotechnology continues to make a substantial impact in the pediatric medical community.

Pediatric cardiac surgeons throughout the United States, Canada, and Europe have experienced the advantages of CryoLife cardiac cryopreserved cardiac allografts when performing cardiac valve replacements and congenital defect reconstructions.  CryoLife cryopreserved cardiac allografts have given pediatric cardiac surgeons multiple options and flexibility, while offering patients the chance to live active, uninhibited lives without the need for anticoagulation therapies.

The commercial availability of CryoLife's cryopreserved human tissue provides cardiac surgeons with a variety of preserved implantable tissues, such as aortic valves, pulmonary valves, and patch materials for cardiac valve replacement and defect repair.  Over the past 20 years, over 800 pediatric cardiac surgeons have implanted over 33,000 cardiac valves and patch materials.  The performance of CryoLife cardiac valves in the demanding pediatric population demonstrates over a decade of dependable integrity and reliability.  In recognition of the importance CryoLife has played in pediatric reconstructive surgery, The CryoKids® Foundation, a non-profit organization, was established to provide cardiac valves for pediatric reconstructive surgery to needy children around the world.

For more information regarding cardiac reconstructive surgery visit: